Suppr超能文献

[Kcnq1ot1促进成骨细胞分化并抑制破骨细胞分化]

[Kcnq1ot1 promotes osteogenic differentiation and suppresses osteoclast differentiation].

作者信息

Zhang Kun, Shi Zhemin, Ren Yi, Han Xiaohui, Wang Jingzhao, Hong Wei

机构信息

Department of Histology and Embryology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2021 Jan 30;41(1):31-38. doi: 10.12122/j.issn.1673-4254.2021.01.04.

Abstract

OBJECTIVE

To investigate the regulatory role of long non-coding RNA Kcnq1ot1 in osteoclast differentiation, osteogenic differentiation and osteoporosis.

METHODS

The expression of lnc-Kcnq1ot1, Bglap, Runx2, Alp, Bsp, Nfatc1, Mmp9, Ctsk and Oscar were detected by real-time quantitative PCR (qRT-PCR) in the femoral bones from mouse models of postmenopausal osteoporosis (ovariectomized mice, =8), disuse osteoporosis (induced by tail suspension, =14) and agerelated osteoporosis (18-month-old mice, =8), and also in MC3T3-E1 cells during osteoblast differentiation and in murine bone marrow-derived macrophages (BMMs) and RAW264.7 cells during osteoclast differentiation. MC3T3-E1 cells with lncKcnq1ot1 knockdown by lentivirus infection were induced to differentiate into osteoblasts using osteogenic induction medium, and the expression of lnc-Kcnq1ot1, Alp and Bglap was detected with qRT-PCR and ALP activity was assessed with ALP staining. BMMs and RAW264.7 cells were transfected with siRNAs targeting lnc-Kcnq1ot1 and stimulated with RANKL and/or M-CSF, and the expression of lnc-Kcnq1ot1, Ctsk and Oscar was detected by qRT-PCR, and TRAP activity was assessed by TRAP staining. The subcellular localization of lnc-Kcnq1ot1 in MC3T3-E1 and RAW264.7 cells was determined using cell fractionation followed by qRT-PCR.

RESULTS

The expression of lnc-Kcnq1ot1 was significantly upregulated during osteoblast differentiation but downregulated in the bone tissues of osteoporotic mice and during osteoclast differentiation ( < 0.05). Silencing lnc-Kcnq1ot1 obviously decreased the expression of Bglap and Alp ( < 0.05) and attenuated osteogenic medium-induced osteoblast differentiation. Knockdown of lnc-Kcnq1ot1 also promoted the expression of Ctsk and Oscar ( < 0.05) and aggravated RANKL-induced osteoclast differentiation. The results of cell fractionation and qRT-PCR demonstrated that lnc-Kcnq1ot1 was located mainly in the nuclei of MC3T3-E1 and RAW264.7 cells.

CONCLUSIONS

Our data demonstrate that lnc-Kcnq1ot1 promotes osteogenic differentiation and alleviates osteoclast differentiation, suggesting the potential of lnc-Kcnq1ot1 as a therapeutic target against osteoporosis.

摘要

目的

探讨长链非编码RNA Kcnq1ot1在破骨细胞分化、成骨细胞分化及骨质疏松症中的调控作用。

方法

采用实时定量PCR(qRT-PCR)检测绝经后骨质疏松小鼠模型(去卵巢小鼠,n = 8)、废用性骨质疏松小鼠模型(尾部悬吊诱导,n = 14)及年龄相关性骨质疏松小鼠模型(18月龄小鼠,n = 8)股骨中lnc-Kcnq1ot1、Bglap、Runx2、Alp、Bsp、Nfatc1、Mmp9、Ctsk和Oscar的表达,同时检测成骨细胞分化过程中MC3T3-E1细胞以及破骨细胞分化过程中鼠骨髓来源巨噬细胞(BMMs)和RAW264.7细胞中上述基因的表达。通过慢病毒感染敲低lncKcnq1ot1的MC3T3-E1细胞,使用成骨诱导培养基诱导其分化为成骨细胞,采用qRT-PCR检测lnc-Kcnq1ot1、Alp和Bglap的表达,通过碱性磷酸酶(ALP)染色评估ALP活性。用靶向lnc-Kcnq1ot1的小干扰RNA(siRNAs)转染BMMs和RAW264.7细胞,并用核因子κB受体活化因子配体(RANKL)和/或巨噬细胞集落刺激因子(M-CSF)刺激,采用qRT-PCR检测lnc-Kcnq1ot1、Ctsk和Oscar的表达,通过抗酒石酸酸性磷酸酶(TRAP)染色评估TRAP活性。采用细胞分级分离结合qRT-PCR确定lnc-Kcnq1ot1在MC3T3-E1和RAW264.7细胞中的亚细胞定位。

结果

lnc-Kcnq1ot1在成骨细胞分化过程中表达显著上调,但在骨质疏松小鼠骨组织及破骨细胞分化过程中表达下调(P < 0.05)。沉默lnc-Kcnq1ot1明显降低Bglap和Alp的表达(P < 0.05),并减弱成骨培养基诱导的成骨细胞分化。敲低lnc-Kcnq1ot1还促进Ctsk和Oscar的表达(P < 0.05),并加重RANKL诱导的破骨细胞分化。细胞分级分离和qRT-PCR结果表明,lnc-Kcnq1ot1主要位于MC3T3-E1和RAW264.7细胞的细胞核中。

结论

我们的数据表明,lnc-Kcnq1ot1促进成骨细胞分化并减轻破骨细胞分化,提示lnc-Kcnq1ot1作为骨质疏松症治疗靶点的潜力。

相似文献

1
[Kcnq1ot1 promotes osteogenic differentiation and suppresses osteoclast differentiation].
Nan Fang Yi Ke Da Xue Xue Bao. 2021 Jan 30;41(1):31-38. doi: 10.12122/j.issn.1673-4254.2021.01.04.
2
Icariin influences adipogenic differentiation of stem cells affected by osteoblast-osteoclast co-culture and clinical research adipogenic.
Biomed Pharmacother. 2017 Apr;88:436-442. doi: 10.1016/j.biopha.2017.01.050. Epub 2017 Jan 22.
3
Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
Phytomedicine. 2020 Apr;69:153195. doi: 10.1016/j.phymed.2020.153195. Epub 2020 Feb 22.
4
Oridonin promotes osteogenesis through Wnt/β-catenin pathway and inhibits RANKL-induced osteoclastogenesis in vitro.
Life Sci. 2020 Dec 1;262:118563. doi: 10.1016/j.lfs.2020.118563. Epub 2020 Oct 7.
5
Chalcone T4 Inhibits RANKL-Induced Osteoclastogenesis and Stimulates Osteogenesis In Vitro.
Int J Mol Sci. 2023 Apr 21;24(8):7624. doi: 10.3390/ijms24087624.
6
Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
Mol Cell Endocrinol. 2019 Aug 20;494:110494. doi: 10.1016/j.mce.2019.110494. Epub 2019 Jun 28.
7
Effect of primary osteoblast-derived extracellular vesicles on osteoclast differentiation.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Aug 25;53(4):434-442. doi: 10.3724/zdxbyxb-2024-0148.
8
lncRNA Kcnq1ot1 promotes bone formation by inhibiting miR-98-5p/Tbx5 axis in MC3T3-E1 cells.
Exp Ther Med. 2022 Mar;23(3):194. doi: 10.3892/etm.2022.11117. Epub 2022 Jan 5.
9
The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation.
Int J Med Sci. 2017 Jul 19;14(9):840-852. doi: 10.7150/ijms.19268. eCollection 2017.
10
[Establish mouse osteoblast -osteoclast cell co-culture system in a Transwell chamber].
Zhongguo Gu Shang. 2018 Mar 25;31(3):241-247. doi: 10.3969/j.issn.1003-0034.2018.03.010.

引用本文的文献

1
Genetic markers associated with bone strength and density in Rhode Island Red laying hens.
Poult Sci. 2025 Jul;104(7):105246. doi: 10.1016/j.psj.2025.105246. Epub 2025 May 2.
3
LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases.
Genes Dis. 2021 Aug 16;9(6):1556-1565. doi: 10.1016/j.gendis.2021.07.003. eCollection 2022 Nov.
4
Research Progress on the Inflammatory Effects of Long Non-coding RNA in Traumatic Brain Injury.
Front Mol Neurosci. 2022 Mar 10;15:835012. doi: 10.3389/fnmol.2022.835012. eCollection 2022.
5
[Expression of RUNX2/LAPTM5 in MC3T3-E1 osteoblastic cells with induced mineralization].
Nan Fang Yi Ke Da Xue Xue Bao. 2021 Aug 31;41(9):1394-1399. doi: 10.12122/j.issn.1673-4254.2021.09.15.

本文引用的文献

1
[Long-chain non-coding RNA MALAT1 regulates paclitaxel resistance of breast cancer cells by targeting miR-485-3p].
Nan Fang Yi Ke Da Xue Xue Bao. 2020 May 30;40(5):698-702. doi: 10.12122/j.issn.1673-4254.2020.05.13.
2
[Serum level of lncRNA TUSC7 in patients with esophageal squamous cell carcinoma and its role in promoting tumor cell migration and invasion].
Nan Fang Yi Ke Da Xue Xue Bao. 2020 May 30;40(5):661-669. doi: 10.12122/j.issn.1673-4254.2020.05.08.
3
LncRNA Kcnq1ot1 renders cardiomyocytes apoptosis in acute myocardial infarction model by up-regulating Tead1.
Life Sci. 2020 Sep 1;256:117811. doi: 10.1016/j.lfs.2020.117811. Epub 2020 May 16.
5
LncRNA KCNQ1OT1 sponges miR-34c-5p to promote osteosarcoma growth via ALDOA enhanced aerobic glycolysis.
Cell Death Dis. 2020 Apr 24;11(4):278. doi: 10.1038/s41419-020-2485-1.
6
KCNQ1OT1 regulates osteogenic differentiation of hBMSC by miR-320a/Smad5 axis.
Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):2843-2854. doi: 10.26355/eurrev_202003_20648.
7
lncRNA KCNQ1OT1 Suppresses the Inflammation and Proliferation of Vascular Smooth Muscle Cells through IκBa in Intimal Hyperplasia.
Mol Ther Nucleic Acids. 2020 Jun 5;20:62-72. doi: 10.1016/j.omtn.2020.01.032. Epub 2020 Feb 4.
8
Silencing of KCNQ1OT1 Decreases Oxidative Stress and Pyroptosis of Renal Tubular Epithelial Cells.
Diabetes Metab Syndr Obes. 2020 Feb 13;13:365-375. doi: 10.2147/DMSO.S225791. eCollection 2020.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验